Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07447960) titled 'LRFN5 and OLFM4 in Schizoaffective Disorder' on Feb. 26.
Study Type: Observational
Primary Sponsor: Elazig Mental Health and Diseases Hospital
Condition:
Schizoaffective Disorder
Recruitment Status: Not recruiting
Date of First Enrollment: March 2, 2026
Target Sample Size: 120
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/NCT07447960
Published by HT Digital Content Services with permission from Health Daily Digest....